Ronald Hunt - Director at Iterum Therapeutics plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ITRM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ronald Hunt since 4/22/2024

Holdings reported by Ronald Hunt for Iterum Therapeutics plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 254K $355K $1.40 Aug 6, 2024 By New Leaf Ventures III, L.P.
Ordinary Shares 91.1K $128K $1.40 Aug 6, 2024 By New Leaf Biopharma Opportunities II, L.P.
Warrants (right to buy) 182K Aug 6, 2024 By New Leaf Ventures III, L.P. Ordinary Shares
Warrants (right to buy) 65.5K Aug 6, 2024 By New Leaf Biopharma Opportunities II, L.P. Ordinary Shares
Subscription Rights (right to buy) 0 Aug 6, 2024 By New Leaf Biopharma Opportunities II, L.P. Units
Subscription Rights (right to buy) 0 Aug 6, 2024 By New Leaf Ventures III, L.P. Units
6.500% Exchangeable Senior Subordinated Note due 2025 $0 Jan 13, 2025 By New Leaf Biopharma Opportunities II, L.P. Ordinary Shares
6.500% Exchangeable Senior Subordinated Note due 2025 $0 Jan 13, 2025 By New Leaf Ventures III, L.P. Ordinary Shares

Transactions reported by Ronald Hunt for Iterum Therapeutics plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.